Back to mobile site

H.C. Wainwright Reiterates Buy Rating on Crescent Biopharma Inc (CBIO)

October 19, 2026 8:09 AM EDT Send to a Friend
H.C. Wainwright analyst Mitchell S. Kapoor reiterated a Buy rating and $36.00 price target on Crescent Biopharma Inc (NASDAQ: CBIO).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login